Literature DB >> 33552782

Streptococcus dysgalactiae Subspecies dysgalactiae Infection Presenting With Septic Shock.

Balamurugan Nathan1, Vivekanandan Pillai2, S Manu Ayyan1, Anuusha Ss1, K N J Prakash Raju1.   

Abstract

Streptococcus dysgalactiae has two main subspecies: Streptococcus dysgalactiae subspecies dysgalactiae (SDSD) and Streptococcus dysgalactiae subspecies equisimilis (SDSE). Although there are various case reports of SDSE causing clinical infection in humans, very few reports of SDSD causing human infections have been reported in the literature. As of date, there are only five case reports of infection with SDSD and all five patients survived the infection. We report a case of a 40-year-old male who presented with features of right upper limb cellulitis and went into septic shock. This report is unique as it presents the first report of SDSD causing fulminant sepsis in humans. Elevation of total fraction of creatinine kinase was also seen in our patient which could be due to myositis or rhabdomyolysis.
Copyright © 2021, Nathan et al.

Entities:  

Keywords:  cellulitis; myositis; rhabdomyolysis; septic shock; streptococcus dysgalactiae subspecies dysgalactiae

Year:  2021        PMID: 33552782      PMCID: PMC7854318          DOI: 10.7759/cureus.12465

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  8 in total

1.  Taxonomic study of lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov.

Authors:  P Vandamme; B Pot; E Falsen; K Kersters; L A Devriese
Journal:  Int J Syst Bacteriol       Date:  1996-07

2.  New tricks from an old cow: infective endocarditis caused by Streptococcus dysgalactiae subsp. dysgalactiae.

Authors:  Stina Jordal; Marte Glambek; Oddvar Oppegaard; Bård Reiakvam Kittang
Journal:  J Clin Microbiol       Date:  2014-12-03       Impact factor: 5.948

3.  Streptococcal myositis.

Authors:  E M Adams; S Gudmundsson; D E Yocum; R C Haselby; W A Craig; W R Sundstrom
Journal:  Arch Intern Med       Date:  1985-06

4.  Human infections due to Streptococcus dysgalactiae subspecies equisimilis.

Authors:  Claudia M Brandt; Barbara Spellerberg
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

5.  Streptococcal cellulitis following preparation of fresh raw seafood.

Authors:  T H Koh; L-H Sng; S M Yuen; C K Thomas; P L Tan; S H Tan; N S Wong
Journal:  Zoonoses Public Health       Date:  2009-03-02       Impact factor: 2.702

6.  Streptococcus dysgalactiae subspecies dysgalactiae infection after total knee arthroplasty: a case report.

Authors:  Man Jun Park; Il-Soo Eun; Chul-Young Jung; Young-Chul Ko; Young-June Kim; Chang-Kyu Kim; Eun-Jin Kang
Journal:  Knee Surg Relat Res       Date:  2012-05-31

7.  Rhabdomyolysis after group C streptococcal infection.

Authors:  Hilde Haugedal Nordal; Bård Reiakvam Kittang; Laurence A Bindoff
Journal:  Infect Dis Rep       Date:  2010-10-01

8.  A Rare Case of Streptococcus dysgalactiae Subsp. Dysgalactiae Human Zoonotic Infection.

Authors:  Suma Sri Chennapragada; Kamleshun Ramphul; Ben J Barnett; Stephanie G Mejias; Petras Lohana
Journal:  Cureus       Date:  2018-07-01
  8 in total
  2 in total

1.  Assessing in vivo and in vitro biofilm development by Streptococcus dysgalactiae subsp. dysgalactiae using a murine model of catheter-associated biofilm and human keratinocyte cell.

Authors:  Cinthia Alves-Barroco; Ana Maria Nunes Botelho; Marco Antonio Américo; Sérgio Eduardo Longo Fracalanzza; António P Alves de Matos; Márcia Aparecida Guimaraes; Bernadete Teixeira Ferreira-Carvalho; Agnes Marie Sá Figueiredo; Alexandra R Fernandes
Journal:  Front Cell Infect Microbiol       Date:  2022-07-19       Impact factor: 6.073

2.  Phylogenetic analysis and accessory genome diversity reveal insight into the evolutionary history of Streptococcus dysgalactiae.

Authors:  Cinthia Alves-Barroco; Patrícia H Brito; Ilda Santos-Sanches; Alexandra R Fernandes
Journal:  Front Microbiol       Date:  2022-07-19       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.